Ardelyx, Inc. (ARDX)
3.58
-0.04
(-1.10%)
USD |
NASDAQ |
Sep 11, 16:00
3.53
-0.05
(-1.40%)
After-Hours: 06:48
Ardelyx Market Cap : 891.95M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 891.95M |
| September 10, 2026 | 901.91M |
| September 09, 2026 | 946.76M |
| September 08, 2026 | 939.28M |
| September 04, 2026 | 941.78M |
| September 03, 2026 | 924.34M |
| September 02, 2026 | 946.76M |
| September 01, 2026 | 936.79M |
| August 31, 2026 | 941.78M |
| August 28, 2026 | 949.25M |
| August 27, 2026 | 951.74M |
| August 26, 2026 | 954.23M |
| August 25, 2026 | 941.78M |
| August 24, 2026 | 931.81M |
| August 21, 2026 | 969.18M |
| August 20, 2026 | 971.67M |
| August 19, 2026 | 1.004B |
| August 18, 2026 | 976.66M |
| August 17, 2026 | 1.012B |
| August 14, 2026 | 1.012B |
| August 13, 2026 | 974.17M |
| August 12, 2026 | 989.11M |
| August 11, 2026 | 981.64M |
| August 10, 2026 | 996.59M |
| August 07, 2026 | 996.59M |
| Date | Value |
|---|---|
| August 06, 2026 | 1.213B |
| August 05, 2026 | 1.223B |
| August 04, 2026 | 1.248B |
| August 03, 2026 | 1.230B |
| July 31, 2026 | 1.223B |
| July 30, 2026 | 1.245B |
| July 29, 2026 | 1.235B |
| July 28, 2026 | 1.256B |
| July 27, 2026 | 1.250B |
| July 24, 2026 | 1.242B |
| July 23, 2026 | 1.267B |
| July 22, 2026 | 1.255B |
| July 21, 2026 | 1.257B |
| July 20, 2026 | 1.257B |
| July 17, 2026 | 1.284B |
| July 16, 2026 | 1.266B |
| July 15, 2026 | 1.309B |
| July 14, 2026 | 1.274B |
| July 13, 2026 | 1.269B |
| July 10, 2026 | 1.304B |
| July 09, 2026 | 1.329B |
| July 08, 2026 | 1.341B |
| July 07, 2026 | 1.329B |
| July 06, 2026 | 1.319B |
| July 02, 2026 | 1.302B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| REGENXBIO, Inc. | 462.02M |
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
| Anika Therapeutics, Inc. | 279.17M |
| Savara, Inc. | 1.089B |
Market Cap Related Metrics
| PS Ratio | 1.944 |
| Price to Book Value | 5.986 |
| Price | 3.58 |
| Earnings Yield | -6.32% |